Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C H Collins

Showing results (21-30 of 86) with videos related to

Pageof 9
Sort By:
Tubercle|June 1, 1983
Mycobacterial pathogenicity and nomenclature: the 'nyrocine mycobacteria'J M Grange, C H Collins
British Journal of Biomedical Science|September 1, 1995
Formaldehyde disinfection in laboratories: limitations and hazardsJ E Cheney, C H Collins
Medical Laboratory Sciences|October 1, 1984
Mycobacterium africanum and the 'African' tubercle bacilliC H Collins, M D Yates
Tubercle|June 1, 1979
Hydroxylamine sensitivity and salt tolerance in screening and identifying mycobacteriaC H Collins, M D Yates
Science (New York, N.Y.)|December 29, 1998
Laboratory safetyC H Collins, D A Kennedy
The Journal of Antimicrobial Chemotherapy|December 1, 1988
In-vitro activity of seventeen antimicrobial compounds against seven species of mycobacteriaC H Collins, A H Uttley
British Journal of Biomedical Science|May 29, 2000
Evolution of microbiological safety cabinetsC H Collins, D A Kennedy
Tubercle|September 1, 1988
In vitro activity of ciprofloxacin in combination with standard antituberculous drugs against mycobacterium tuberculosisA H Uttley, C H Collins
Journal of Clinical Pathology|January 1, 1984
The Howie Code: what are the real costs?C H Collins, J W Howie
The Journal of Applied Bacteriology|August 1, 1983
The bovine tubercle bacillusC H Collins, J M Grange
Pageof 9

Showing results (21-30 of 86) with videos related to

Sort By:
Pageof 9
Tubercle|June 1, 1983
Mycobacterial pathogenicity and nomenclature: the 'nyrocine mycobacteria'J M Grange, C H Collins
British Journal of Biomedical Science|September 1, 1995
Formaldehyde disinfection in laboratories: limitations and hazardsJ E Cheney, C H Collins
Medical Laboratory Sciences|October 1, 1984
Mycobacterium africanum and the 'African' tubercle bacilliC H Collins, M D Yates
Tubercle|June 1, 1979
Hydroxylamine sensitivity and salt tolerance in screening and identifying mycobacteriaC H Collins, M D Yates
Science (New York, N.Y.)|December 29, 1998
Laboratory safetyC H Collins, D A Kennedy
The Journal of Antimicrobial Chemotherapy|December 1, 1988
In-vitro activity of seventeen antimicrobial compounds against seven species of mycobacteriaC H Collins, A H Uttley
British Journal of Biomedical Science|May 29, 2000
Evolution of microbiological safety cabinetsC H Collins, D A Kennedy
Tubercle|September 1, 1988
In vitro activity of ciprofloxacin in combination with standard antituberculous drugs against mycobacterium tuberculosisA H Uttley, C H Collins
Journal of Clinical Pathology|January 1, 1984
The Howie Code: what are the real costs?C H Collins, J W Howie
The Journal of Applied Bacteriology|August 1, 1983
The bovine tubercle bacillusC H Collins, J M Grange
Pageof 9